Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.

A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov. 2011 Jun; 1(1):68-77.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.